Stem Cell Treatment for Lupus

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for Lupus

Recruiting Phase 1 Interventional Study
Lupus
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Treatment
Participants needed
15 (estimated)
Sponsor
The Foundation for Orthopaedics and Regenerative Medicine · Other
Who this trial is looking for

This trial is looking for people with lupus to join a study. Participants will receive an infusion of stem cells derived from umbilical cord blood to see if it helps their condition.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with lupus
  • I understand and am willing to sign a consent form

You may not be able to join if

  • I have an active infection
  • I have active cancer
  • I have chronic multisystem organ failure
  • I am pregnant
  • I have significant abnormalities in my lab tests before treatment
  • I have a medical condition that may compromise my safety
  • I continue to abuse drugs
  • I am a pre-menopausal woman not using contraception

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Lupus

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of Lupus * Understanding and willingness to sign a written informed consent document Exclusion Criteria: * Active infection * Active cancer * Chronic multisystem organ failure * Pregnancy * Clinically significant Abnormalities on pre-treatment laboratory evaluation…
Contacts

No contact information available.